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Current brachytherapy treatment planning systems are unable to accurately 
calculate dose distributions in the vicinity of brachytherapy sources having active lengths 
much greater than 5 mm. While low dose-rate 137Cs sources are dosimetrically 
characterized using antiquated along-away tables with simple linear-linear interpolation 
errors in dose calculation exceeding 30% occur due to algorithm inadequacy. The method 
presented in this thesis permits dosimetric characterization of elongated brachytherapy 
sources with active lengths 0 < L < 10 cm for implementation on an FDA-approved 
clinical TPS. Low- and high-energy photon-emitting sources of 103Pd and 192Ir, 
respectively, were examined. 
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1 1 CHAPTER 1 
INTRODUCTION 
Radiation has been used for over a century as a method to combat the spread of 
cancer. 1 , 2  Soon after clinical application of external radiation sources, the idea of 
implanting radioactive sources into diseased tissue was considered.3 This modality is 
known as brachytherapy and was first utilized prior to the First World War. Small seeds 
have been used as the radiation source for much of the recent history of brachytherapy. In 
the past decade, the technology used to make brachytherapy sources has developed to a 
point where threadlike structures are now readily available with high pliability and a 
uniform radioactivity distribution. 
Arguably, the most important job of the medical physicist is accurately 
determining the dose a patient is going to receive during treatment. Much work has been 
accomplished by the radiotherapy community to improve the ability of medical physicists 
to predict the dose. For brachytherapy, this has meant modeling the dose distribution 
from a small source. At the outset of the modality, look up tables were used to estimate 
dose. 4,5,6 As technology became more complex, so did the algorithms; particularly when 
computers became commonplace. Currently, these algorithms superimpose precalculated 
source dose distributions over patient anatomy that is obtained using either CT or MRI 
data so that the dose estimation is determined for each individual patient implant. The 
American Association of Physicists in Medicine (AAPM) Task Group 43 (TG-43) 
established the global standard for brachytherapy dose calculation using these algorithms. 
7,8,9 
The current approach for dose calculation relies on superposition of single-source 
dose distributions obtained in a liquid water phantom of a fixed volume for radiation 
scattering. The dose distribution is assumed to be cylindrically symmetrical. Dose from 
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each source is calculated and then the total dose from all sources is taken to be the sum of 
the individual sources.  
This model works well for brachytherapy seeds with active lengths L < 0.5 cm; 
however, the medical community is considering the use of sources that cannot accurately 
be modeled as point sources.10,11,12 Elongated sources, assumed to be substantially greater 
than 0.5 cm in length, have a different dose profile than conventional brachytherapy 
sources because of attenuation along the length of the source. Additionally, the point-
source approximation breaks down at close distances from the source (i.e., r < L), making 
it inadequate to consider the elongated source as merely the sum of a series of individual 
seeds. While a line source can be modeled using Monte Carlo methods for radiation 
transport simulations, this computational process is too resource intensive for most 
hospitals to be considered for individualized patient treatment planning in a clinical 
setting. The series of AAPM TG-43 reports (i.e., Nath et al. 1995, Rivard et al. 2004, 
Rivard et al. 2007) mentioned above were developed specifically for seed-like sources 
and therefore has a few specific problems that need to be addressed in order for accurate 
dose calculations to be made within the treatment planning systems (TPS). 
This thesis aimed to determine if an elongated source can be accurately modeled 
using smaller lengths. The goal was to develop a mathematical model that combined 
smaller sources in such a way that the dose distribution was sufficiently similar to the 
elongated brachytherapy source. Monte Carlo simulations were conducted to evaluate the 
dose distributions of various lengths of 103Pd and 192Ir. This work was performed in 
conjunction with the AAPM TG-143, which has the charge of developing a new dose 
calculation formalism and associated guidelines for clinical implementation of elongated 
brachytherapy sources of photon emitting radionuclides. 
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2  CHAPTER 2 
BACKGROUND 
Manufacturers produce radioactive sources in a variety of shapes, increasing the 
clinical possibilities for brachytherapy treatment. One particular shape that needs further 
investigation is a flexible threadlike source which may be cut to the desired length. 
2.1 AAPM TG-43 Dosimetry Protocol for Interstitial Brachytherapy Sources 
The AAPM TG-43U1 formalism is currently used in brachytherapy TPS to 
calculate clinical dose distributions.8 The formalism has 1D and 2D formats: the point-
source approximation and the line-source approximation. The latter formalism is 














K  (1) 
where r is the distance (cm) from the center of the active source to the point of interest, θ 
is the polar angle (degrees) to the point of interest, SK is the air-kerma strength of the 
source (μGy m2 h-1), Λ is the dose-rate constant, GL(r,θ) is the line-source geometry 
function, gL(r) is the line-source radial dose function, and F(r,θ) is the 2D anisotropy 
function. The subscript 0 refers to the reference point, which is taken to be r01 cm and 








Figure 2-1 Coordinate system used for brachytherapy dosimetry calculations in TG-43U. 
The dose-rate constant, Λ, is defined as the ratio of dose rate to water at the reference 
position in a water phantom divided by the source air-kerma strength.  
KS
rD ),( 
  (2) 
The geometry function accounts for the spatial distribution of radioactivity within the 
source. For the purposes of this thesis, the source geometry is cylindrically-symmetric as 































where β is the angle (radians) that is subtended by the ends of the hypothetical line source 
with respect to the point of calculation. (See Figure 2-1) gL(r) takes into account the 
















  (4) 
F(r,θ) corrects for the change in dose as the polar angle changes for a fixed radius when 















  (5) 
2.2 Dose calculation models for elongated brachytherapy sources 
Karaiskos’ Method 
The first of the methods that is being used for comparison was published by 
Karaiskos et al.10,13 Limiting their calculations to source lengths between 3.0 cm and 7.0 
cm, and using the TG-43 formalism, the parameters necessary to calculate dose are 
calculated in the following way. 
1. Tables exist for F(r,θ) for 3.0 cm, 5.0 cm and 7.0 cm. Values of F(r,θ) are 
interpolated from these existing tables.  
2. g(r) is set equal to g(r) for L = 5.0 cm. 
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From these parameters, it is possible to calculate the dose using the TG-43 formalism. 
The Karaiskos’ Method has drawbacks in clinical implementation. First, the dose 
for L < 3.0 cm cannot be calculated using this method, which is not a reasonable 
condition to place upon clinical practice given the goal of developing a general dose 
calculation method for elongated brachytherapy sources. Second, it is not possible to 
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calculate dose for lengths that are curvilinear, a clear drawback in clinical situations as 
bending of the elongated source is most likely to occur after implantation. If a physician 
would like to place a source along the seam of a surgical cut, for example in a lung 
resectioning that would benefit from additional radiation treatment to improve the 
likelihood of cancer eradication, it becomes necessary to bend the source length to 
conform to the tumor bed. Third, this method cannot be used in a conventional 
brachytherapy TPS. In most brachytherapy TPS, F(r,θ) and g(r) are the dosimetry 
parameters with values that are inputted by then clinical brachytherapy dose calculations 
are performed. The Karaiskos’ Method deviates unacceptably from the AAPM TG-43 
dose calculation method for this to be implemented in a conventional brachytherapy TPS. 
For example, Λ has a novel definition in the Karaiskos’ Method, as does GL(r,θ). Because 
there is no way to alter the methods used in the TPS to calculate the parameters, this 
method is rendered unusable clinically with current brachytherapy TPS. 
Point-segmented source method (PSS) 
Developed by Meigooni et al,11 the PSS Method approximated a linear 
brachytherapy source by dividing it into 0.5 or 1.0 cm lengths and then treating each 
length as if it was a point source. In order to calculate a series of point sources, Meigooni 
et al used the AAPM TG-43 1D dose calculation formalism that is contained in the 
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This 1D formalism is similar to that of the 2D formalism. F(r,θ) has been replaced with a 















  (9)14 
The simulation was a straightforward approximation, where the extended source 
was broken up into segments, and the formalism was then applied. Two geometries were 
calculated: the first divided a 3.0 cm segment into six points spaced 0.5 cm apart while 
the second divided a 3.0 cm segment into three points spaced 1.0 cm apart. Once the 
point sources were positioned, the superposition principle was applied, summing the 
contribution from each point at every point in the grid location within the volume of 
interest.  
3.0 cm line source
0.5 cm point spacing
1.0 cm point spacing
 
Figure 2-2 Point-segmented source method to approximate a 3.0 cm long brachytherapy source 
using spacing of 0.5 cm and 1.0 cm. 
In order to account for radiation attenuation along the source long-axis, the point 
source parameters were calculated with dummy seeds in place as well, in addition to the 
simulations outlined above. The point source was placed in and amongst placement 
holders for source lengths in order to assure that proper attenuation conditions were met. 
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3.0 cm line source
0.5 cm point spacing
1.0 cm point spacing
 
Figure 2-3 Attenuation correction for PSS. The circles represent the placement of point sources in 
the Monte Carlo simulations while the lines are dummy source lengths that were placed to 
account for attenuations conditions. 
Monte Carlo simulations were calculated for the 3.0 cm RadioCoil™ using a dose 
grid of 0.5 cm spacing in the z (along the length of the source) and y (away from the 
source) directions. (See Figure 2-4) Additionally, in order to implement the PSS Method 
in the brachytherapy TPS, the parameters necessary to perform the dose calculations 
using the AAPM TG-43 formalism were calculated using Monte Carlo simulations as 
well. The parameters were inputted into brachytherapy TPS and the PSS Method was 





Figure 2-4 Coordinate system used for PSS, LSS, and TLS Methods 
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For points where y ≥ 1.0 cm, the PSS Model under-approximated the Monte Carlo 
calculated dose by as much as 8% for the 0.5 cm spacing and by 12% for the 1.0 cm 
spacing. For y < 1.0 cm, these errors increased further. Differences as high as 34% at 
specific points were reported.  
One concern with the PSS Method is the dose grid size used for the Meigooni et 
al Monte Carlo simulations. The calculation dose grid was 1.0 mm and volume averaging 
over the voxels smoothed out dose distributions in regions with higher gradients. 
Additionally, the PSS Method limitations in source length (L < 3.0 cm can not be 
modeled), which makes this method unusable in a clinical setting.  
Line-segmented source (LSS) Method  
The LSS Method is similar to the PSS Method, except instead of using point 
sources to model the active lengths of radioactivity, line segments were used, in 0.5 and 
1.0 cm lengths. (See Figure 2-5 and Figure 2-6) 
1.0 cm line spacing
0.5 cm line spacing
3.0 cm line source
 
Figure 2-5 LSS approximation for a 3.0 cm length, using spacing of 0.5 cm and 1.0 cm. 
The 2D formalism introduced in the AAPM TG-43U1 report was used in the LSS 
Method in order to perform calculations in the TPS. Monte Carlo simulations were 
performed to obtain the parameters necessary for TG-43 implementation in the TPS.  
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3.0 cm line source
0.5 cm line spacing
1.0 cm line spacing
 
Figure 2-6 Attenuation correction for LSS. The thick lines are the sections that are radioactive. 
The thin lines represent dummy sources that were placed in the Monte Carlo simulations to 
account for attenuations. 
For both simulations, meaning when the 3.0 cm source was divided into 6 
segments or 3 segment, comparison of the Monte Carlo simulation and the dose 
calculations performed by the TPS using the LSS model (without source attenuation) 
showed 4% agreement when θ = 90°, for values of r ranging from 0.5 cm to 2.0 cm. 
However, the differences were as high as 14%, which occurred at θ = 14° and r = 2.06 
cm. When source attenuation was taken into account, differences increased even further 
to as much as 21%, again along the length of the source, just outside of the cap (1.5 cm < 
z < 2.5 cm).  
Close distance approximation discrepancies were high enough to render this 
method unusable in clinical settings, as the AAPM usually demands a standard of care 
with accuracy of at most 3%. Additionally, the LSS Method suffers from many of the 
same problems as the PSS Method by not being implementable in the clinic and it cannot 
approximate lengths less than 3.0 cm with conventional brachytherapy TPS. 
Two-line-source (TLS) Method 
The TLS method to correct for dose anisotropy along the source length was 
developed by van der Laarse et al.12 For L > 1.5 cm, the total length is divided into two 
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lengths: two peripheral lengths ranging between 0.75 cm and 1.25 cm, and a series of 1.0 
cm inner lengths. For example, a 4.4 cm length would be divided into four segments: two 
outer segments of 1.2 cm each and two inner segments of 1.0 cm. To determine the 
various components for dose calculation, the following rules are used. 
1. The geometry function is calculated according to the expression recommended by 
the AAPM TG-43U1 formalism for a line source: 
Λ is obtained in a way similar to that used by Karaiskos et al10 by interpolating or 
extrapolating over the Λ values for 0.5 and 1.0 cm wires and correcting for the 
geometry by dividing out GL(r,θ) for both lengths:  
0.5cm 1.0cm 0.5cm
0 0 0.5 0 0 1 0 0 0.5 0 0
0.5cm




G r G r G r G r   
    
     
 (10) 
2. If a wire length is smaller than 1.0 cm, gL(r)F(r,θ) are interpolated from tables 
containing data for L = 0.5 and L = 1.0 cm.  
3. g0.5cm(r) = g1.0cm(r), therefore g1.0cm(r) is used for all lengths.  
The TLS Method was a great improvement over the previously mentioned 
methods. Agreement with Monte Carlo simulations was 5.6% along the central axis of 
the source and some locations within the grid space had agreement within 2%. However, 
this method suffers from the same problem of an inability to readily apply it in a clinical 
setting. Λ has a novel definition in this study that differs from that which is used in the 
TPS, although this could be calculated offline as it is a scalar value. However, with the 
change in definition of gL(r) and F(r,θ), and the complexity of the calculations in the TLS 
Method, this would become a non-trivial problem that would need to be overcome for 
clinical use. Therefore, the TLS Method is rendered unusable outside of theoretical uses 
within the bounds of research.  
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2.3 Areas for improvement and rationale for research 
As has been previously stated, the methods described in the literature suffer from 
a myriad of problems, the most pressing one being a lack of implementability within the 
current TPS models for brachytherapy calculations. In order for a method to be 
considered useful clinically, it needs to solve for gL(r) and F(r,θ) while using the standard 
definition for the geometry function. Additionally, the method needs to be usable for any 
length that may possibly be used clinically, which is technically only limited to the 
lengths that are produced by the vendors.  
In this work, we take the first steps in the development of a method that will 
divide lengths into smaller segments that are more manageable. Using Monte Carlo 
simulations for various lengths of straight wire, we determined gL(r) and F(r,θ) using the 
Tufts technique developed by Rivard et al.15 Unlike previous methods, this technique 
does not redefine any of the parameters that are laid out by TG-43U, which ensures that 
the method may be implemented within a conventional brachytherapy TPS. Once gL(r) 
and F(r,θ) are calculated for each length, this data was inputted into the Pinnacle TPS (v 
8.0m, Phillips Medical Systems, Cleveland, OH). Using the Pinnacle TPS, a variety of 
lengths were compared to test the efficacy of the method. This testing was performed 
with the IBA Dosimetry OmniPro I’mRT radiation dosimetry software (v.1.6, ibaDosimetry, 
Schwarzenbruck, Germany). 
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3  CHAPTER 3 
METHODS 
3.1 Overview 
In order to ensure the ability to use our method within the TPS, data necessary for 
input was identified. As the method implemented by the TPS was based on the updated 
AAPM TG-43 formalism, we used that as our guiding principle. For calculating the dose, 
it is necessary to provide the TPS with gL(r), F(r,θ) and Λ. These values are length 
dependent, so it becomes necessary to input these functions for each length that is 
intended to be used in the TPS.  
It was decided that we would model both a 3.0 cm length and 5.0 cm length using 
various smaller lengths and compare that data to Monte Carlo simulations. These lengths 
were chosen for comparison to Meigooni et al.11 (3.0 cm) and van der Laarse et al.12 (5.0 
cm). To that end, Monte Carlo simulations were performed for a variety of lengths for 
both radionuclides and each Monte Carlo simulation was then used to calculate gL(r) and 
F(r,θ) for each length. These values were inputted into the TPS, and the TPS was used to 
“build” longer brachytherapy sources from various smaller lengths. 
3.2 Geometry of wires 
Two types of brachytherapy wires (103Pd and 192Ir) were modeled. 
Palladium 
The 103Pd RadioCoil™ geometry was used in order to ensure that results were 
comparable to previously published work by the Meigooni team. RadioCoil™ sources are 
a flat ribbon of cyclotron-activated 102Rh (ρ = 12.45 g/cm3), which produces radioactive 
103Pd uniformly distributed throughout by the 102Rh(p,n)103Pd reaction. This metal is then 
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coiled into a 0.8 mm outer diameter ribbon with a hollow core, with lengths ranging from 
1.0 cm to 6.0 cm at 1.0 cm increments. The core was taken to be water (ρ = 0.998 g/cm3) 
instead of air. This was justified by running a Monte Carlo simulation with an air core 
and comparing it to the same length with a water core. The ratio of the results from a 
water core to those of an air core averaged 1.0061 along the transverse plane and 1.0070 
throughout the space. One 3.0 cm length Monte Carlo simulation was completed with a 
core of air to ensure that the results with a water core were accurate. See Figure 3-1. 
 
Figure 3-1 103Pd RadioCoil™ geometry 
Iridium 
The 192Ir model used was comparable to what has already been published in the 
literature by the van der Laarse team. The wire is platinum encapsulated with a 0.1 mm 
core that is 192Ir (ρ = 21.68 g/cm3) with a 0.1mm sheath of platinum (ρ = 21.45 g/cm3), 




Figure 3-2 192Ir geometry 
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3.2 Monte Carlo methods for radiation transport 
Monte Carlo simulations were performed on the MCNP5 v5 cluster established by 
Prof. Rivard at Tufts Medical Center and the photoatomic cross sections based on 
EPDL97. 16,17,18 The nine good practices for Monte Carlo simulations, as laid out in 
AAPM TG-43U, were followed.8 For both radionuclides, source lengths of 0.1 cm 
through 1.0 cm (step 0.1 cm), 1.5 cm, 2.0 cm, 2.5 cm, and 3.0 cm through 10.0 cm (step 
1.0 cm) were calculated. Cylindrical coordinates were used for the sampling geometry, 
with the y-axis defined along the source and the z-axis is away from the source. (Figure 
2-1) The origin was placed in the center of the source segment. While reviewing the 
results of previous studies, we questioned whether the sampling space had adequate 
spatial resolution to accurately estimate the dose distribution. In order to ensure 
appropriate resolution, the MC spatial resolution was 0.05 cm, although the range varied 
for the two radionuclides. In both cases, the Monte Carlo simulations calculated kerma 
using linear track-length estimators or energy deposition (F6 tally) and the Monte Carlo 
output was in MeV/g/starting particle, which directly correlates to absorbed dose rate, so 
further calculations were not needed to obtain the absorbed dose rate.19,20  
An F6 tally track-length estimator for kerma was used for computational 
efficiency since differences with an absorbed dose estimator (e.g., *F8 MCNP5 tally) 
would be negligible over the regions examined and for the photon energies of the two 
radionuclides. In the case of 103Pd, the low-energy source, this assumption was safe since 
the secondary charged particle (i.e., electron) range was much less than the voxel size. 
For the high-energy photo-emitter 192Ir, secondary particle/electron range and electron 
emissions from the thinly encapsulated source needed consideration. Ballester et al. 
reported that collisional kerma and absorbed dose are equivalent within 1% beyond 0.6 
mm from an 192Ir source.21 Additionally, they reported that the electron component to 
dose exceeded 1% only for r < 0.2 cm. To test this further for the source geometries used 
in this thesis, 1) an F6 collisional kerma tally was compared to a *F8 absorbed dose tally, 
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both with photon and electron transport, and 2) a *F8 tally with a pure photon-emitting 
source was compared to the same estimator also having electron source contributions, 
again with photon and electron transport.21 These comparisons were performed using the 
5.0 cm long 192Ir source. The kerma:dose comparison yielded an average ratio of 
1.000±0.001 (k = 1 ) for 0.2 < r < 5.0 cm. The electron contribution to total dose for 0.2 < 
r < 5.0 cm was less than 0.1% ± 0.05% which was in good agreement with Ballester et al. 







Figure 3-3 Monte Carlo coordinate system. Cylindrical voxels were used to calculate the dose 
from the source. The voxels were defined by z, the distance along the source and y, the distance 
away from the source.  
Monte Carlo simulations of the 103Pd sources 
The 103Pd photon spectrum used was taken from the NuDat database.22 The dose 
grid ranged from 0 cm < z <10 cm and 0.2 cm < y < 12.5 cm, placed in a spherical water 
phantom with a radius of 15.0 cm (ρ = 0.998 g/cm3). On average, the statistical 
uncertainty of the runs was 0.0111. See Table 3-1. 
Monte Carlo simulations of the 192Ir sources 
The 192Ir photon spectrum used was taken from the NuDat database.23 The 192Ir β 
spectrum was not considered as it does not significantly contribute to the dose in this 
case.21 The dose grid ranged from 0 cm < z <15 cm and 0.2 cm < y < 12.5 cm, placed in a 
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spherical water phantom with a radius of 40.0 cm (ρ = 0.998 g/cm3). On average, the 
statistical uncertainty of the runs was 0.0026. See Table 3-1. In the case of both 103Pd and 
192Ir, the y-axis dose grid began at 0.2 cm so that all the voxels were outside of the source.  
Table 3-1 Average statistical uncertainties for each of the Monte Carlo simulations 
Length (cm) 192Ir 103Pd 
0.1 0.00246 0.01076  
0.2 0.00325 0.01426  
0.3 0.00248 0.01096  
0.4 0.00240 0.01100  
0.5 0.00238 0.01134  
0.6 0.00314 0.01478  
0.7 0.00314 0.01489  
0.8 0.00231 0.01503  
0.9 0.00232 0.01079  
1.0 0.00239 0.01117  
1.5 0.00243 0.01116  
2.0 0.00250 0.01063  
2.5 0.00248 0.01094  
3.0 0.00248 0.01081  
4.0 0.00247 0.01043  
5.0 0.00256 0.00952  
6.0 0.00294 0.01257  
7.0 0.00291 0.00891  
8.0 0.00305 0.00874  
9.0 0.00230 0.00799  
10.0 0.00217 0.00724  
3.3 Preparing Monte Carlo output data for TPS input 
In order to use Pinnacle to independently calculate the dose distributions, the data 
for gL(r) and F(r,θ) needed to be derived using the output from the Monte Carlo 
simulations, which was done using the Tufts technique.15 The Tufts technique takes the 
following steps: 1) identify the cylindrical axis of symmetry of the dose distribution, 2) 
identify the effective length Leff, 3) derive the effective radial dose function, 4) derive the 
2D anisotropy function and 5) choose a virtual dose-rate constant at the reference point 
that reproduces the dose values yielded by the Monte Carlo simulations. The geometry 
function, GL(r,θ), was calculated based on the 2004 AAPM TG-43U1 recommendations, 
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as explained above, which was then used in conjunction with the MCNP5 output data. 














  (11) 
Setting F(r,θ0) = 1, the data for g(r)F(r,θo) = g(r). By plotting g(r)F(r,θo), it 
becomes possible to calculate g(r) for any r, as there is no angular dependence. Excel 
trendline tools were used to determine formulas that accurately described the various 
regions of the graph. The behavior of the graph had three distinct regions: y < 1.0 cm, 
1.0 cm ≤ y ≤ ymax, and y > ymax, ymax being the farthest tabulated distance on the transverse 
plane (y-axis) by the Monte Carlo simulations (Figure 3-4 and Figure 3-5). Beyond ymax, 
it was then necessary to extrapolate the data, since the TPS extends beyond the range 
given by ymax. For 
192Ir, ymax = 12.5 cm and for 
103Pd, ymax = 10.0 cm.  
In the first region, y < 1.0 cm, the dotted line in Figure 3-4 and Figure 3-5, a 
fourth-order polynomial was used to estimate the shape of the curve. For this region of 
the graph, there were only 17 data points in each case and the fourth order was visually 
the best fit for the data, resulting in R2 > 0.999 in all cases. In the region where 
1.0 cm < y < ymax, the solid line in Figure 3-4 and Figure 3-5, a sixth-order polynomial 
was used, again because, for both radionuclides, the polynomial fit the graph best and 
R2 > 0.999 in all cases. The third region had to be treated differently for 103Pd and 192Ir 
because the drop-off at large distances was greater for 103Pd. The initial plan for 
characterizing the region defined by y > ymax was that a linear extrapolation would be 
appropriate, given the shape of the curve in the far region. Intending to use the last few 
data points from the given data, linear approximations were made for both graphs. When 
this was done for 192Ir, the linear approximation was reasonable and fit the curve nicely. 
However, for 103Pd, the linear approximation resulted in a g(r) curve that fell below zero, 
which is not physically possible. As the values at the far distance were so close to zero, 
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when the values were being tabulated for r > ymax, a nearest neighbor extrapolation was 
used setting g(r > ymax) = g(ymax), meaning that when r > ymax, the value of g(r) at that 
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Figure 3-4 g(r)F(r,θ0) for 














0 2 4 6 8 10
 
Figure 3-5 g(r)F(r,θ0) for 
192Ir The dashed portion is for 0.2 < r < 1.0 cm. 
The TPS requires that g(r) and F(r,θ) be put in terms of g(y) and F(y,z). In order 
to relate one to the other, simple geometry was used. The following equations explain the 
relationship.  




     
   (13) 
In this Cartesian coordinate system, it is simple to use the z and y coordinates to 
determine the correct g(r) for any point, using equation 12. The angular component is 
taken into account during GL(r,θ) calculation. For each length, the values of g(r) were 
tabulated for a grid that went from 0 to ymax in both the z and y direction. Using these 
tables, FFIT(r,θ) was calculated in the following way:  
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   (14) 
It is not necessary to make any correction for the angular component of FFIT(r,θ) because, 
as stated above, this was already satisfied in the calculation of GL(r,θ). In the region 
r<0.2 cm, a nearest neighbor extrapolation was applied in order to complete the table. 
These values were then tabulated into two tables for each radionuclide length. Once these 
two tables were derived for each source length, the resolution of both tables was reduced 
as TPS have limitations in terms of grid size. Further, high-resolution exceeded clinical 
requirements. Because of these factors, the resolution of the fit of g(r) and F(r,θo) were 
set to 0.2 cm and 0.1 cm respectively. In the case of 103Pd, 0.0 cm ≤ gFIT(r0) ≤ 15.0 cm, 
step 0.2 cm (51 datapoints) and FFIT(r,θ) spanned from 0.0 cm ≤ y ≤ 10.0 cm, step 0.1 cm, 
and 0.0 cm ≤ z ≤ 10.0 cm, step 0.1 cm (10,201 datapoints). This meant that for 192Ir, 0.0 
cm ≤ gFIT(r0) ≤ 20.0 cm, step 0.2 cm (101 datapoints) and FFIT(r,θ) spanned from 0.0 cm 
≤ y ≤ 15.0 cm, step 0.1 cm, and 0.0 cm ≤ z ≤ 12.5 cm, step 0.1 cm (19,027 datapoints). In 
order to speed the process and ensure accuracy, this data was converted into a computer 
script that automated data input into the Pinnacle TPS.  
3.4 Pinnacle TPS 
To evaluate the accuracy of the method, it was decided to create a series of 3.0 cm 
segments and 5.0 cm segments, made up from various lengths in order to complete the 
comparison with the published literature. 3.0 cm was broken into 1, 3, 4, 5, 6, 10, 15 and 
30 segments. 5.0 cm was broken into 2, 5, 10, 25 and 50 segments. Table 3-2 details the 
3.0 cm lengths used for each trial and Table 3-3 details the 5.0 cm lengths used.  
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Table 3-2 Segment lengths used in Pinnacle to approximate a 3.0 cm source length. 
Segment length (cm) Number of Segments Source Strength (U) 
3.0 1 1.0000 
1.5 2 0.5000 
1.0 3 0.3333 
0.8/0.7 4 (2 each) 0.2667, 0.2333 
0.6 5 0.2000 
0.5/1.0 4 (2 each) 0.1667, 0.3333 
0.5 6 0.1667 
0.3 10 0.1000 
0.2 15 0.0667 
0.1 30 0.0333 
Table 3-3 Segment lengths used in Pinnacle to approximate a 5.0 cm source length 
Segment length (cm) Number of Segments Source Strength (U) 
5.0 1 1.000 
2.5 2 0.500 
1.0 5 0.200 
0.5 10 0.100 
0.2 25 0.040 
0.1 50 0.020 
Within Pinnacle TPS, the calculation space (Table 3-4) was chosen to be large enough to 
ensure an accurate depiction of the dose distribution. The dose grid was limited by the 
TPS and was set to 0.2 cm. In clinical practice, 0.2 cm accuracy for a brachytherapy 
source placement is adequate. 
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Table 3-4 Description of the calculation space within Pinnacle where dose calculations were 
performed. The X axis described the plane that the source was placed in, the Y axis is along the 
source, and the Z axis is away from the source.  
 X Y Z 
Calculation Space    
Voxel Size (cm) 0.25 0.25 0.25 
Data Points 208 208 208 
Spatial Extent (cm) 52.0 52.0 52.0 
 
Dose Grid    
Voxel Size (cm) 0.2 0.2 0.2 
Data Points 3 201 201 
Spatial Extent (cm) 0.6 40.2 40.2 
This calculated space was duplicated for all of the line source configurations in Table 3-2 
and Table 3-3. Each configuration was then built within the TPS, calculated, and the data 
exported. 
3.5 IBA Dosimetry OmniPro-I’mRT 
In order to compare the results of the 3.0 cm line segments with the various 
configurations, OmniPro-I’mRT by IBA Dosimetry was used. There were a number of 
reasons that this type of analysis was performed. Fluence maps, depicting dose 
distributions, can be exported from Pinnacle and directly imported into OmniPro-I’mRT 
without any formatting. Extra steps to perform the comparisons within Excel would have 
been required. OmniPro-I’mRT can perform all of the same calculations that Excel can 
handle without programming, as well as allowing visual depictions of the dose 
distributions comparisons. 
The Gamma method 24 was employed to compare the dose of the L = 3.0 cm or L 
= 5.0 cm source lengths to all configurations from Table 3-2 and Table 3-3, respectively, 
to the dose at the same point. This permitted a threshold both in terms of distance and 
dose. The calculation that the software performs is defined by the following: 
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mccm rrrrr ),(  and 
mmcccm rDrDrr ),(  
rm is the position of a single measurement point, rc is the spatial location of the 
calculated distribution relative to the measurement point, ΔdM is the passing criteria for 
isodose distance, ΔDM is the passing criteria for dose, Dc(rc) is the calculated dose in rc 
and Dm(rm) is the measured dose in rm. Two comparisons were done. The more strict 
comparison defined ΔdM as 0.1 cm and ΔDM was chosen to be 1%. Additionally, ΔDM was 
chosen to be 2% (ΔdM remained the same) for comparison. 
25 
4  CHAPTER 4 
RESULTS AND DISCUSSION 
4.1 Excel comparison 
As a quick check of principle, the superposition principle was applied within 
Excel, taking the MC output files and directly using them to sum to various lengths. The 
same comparisons were made in Excel as were made in OmniPro I’mRT, as detailed in 
Table 3-2 and Table 3-3. In all cases, the superposition principle worked as expected. 
Along the transverse plane, the average ratio of the superposition to the solid source was 
1.007 for 103Pd and 0.999 for 192Ir. Overall, the average ratio over the whole grid was 
1.051 for 103Pd and 1.009 for 192Ir. For both 103Pd and 192Ir, the instances where the 
sources were made up of variable lengths (i.e. two 0.5 cm lengths and two 1.0 cm lengths) 
produced the worst results, particularly along the transverse plane. One reason for this 
could be that the segments were treated as if they had the same activity. However, 
weighting of the segments would have to reflect the relative mass that each length 
comprises. Results improved as the number of lengths used were reduced, with the best 
results stemming from the long source (3.0 cm or 5.0 cm) being divided into two pieces 
(1.5 cm or 2.5 cm). This was expected because the approximation of attenuation along 
the length of the source is more accurate for a longer segmentation (or fewer segments).  
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Table 4-1 The ratio of the segmented source to the full source in Excel using the raw 103Pd Monte 
Carlo data. 
   Excel Superposition ratios 
Total Length 
(cm) Length of Segments 
Number of 
Segments Average Max Min 
Transverse 
plane average 
3 1.5 cm 2 1.009 1.212 0.901 1.001 
3 1.0 cm 3 0.999 1.188 0.681 1.008 
3 2x0.5 cm + 2x1.0 cm 4 1.056 1.479 0.373 0.966 
3 2x0.8 cm + 2x0.7 cm 4 1.025 1.234 0.735 1.002 
3 0.6 cm 5 1.018 1.218 0.635 1.015 
3 0.5 cm 6 1.026 1.251 0.561 1.016 
3 0.3 cm 10 1.088 1.328 0.956 1.031 
3 0.2 cm 15 1.130 1.424 0.969 1.049 
3 0.1 cm 30 1.011 1.525 0.685 0.763 
       
5 2.5 cm 2 1.004 1.150 0.933 1.000 
5 1.0 cm 5 1.019 1.168 0.957 1.011 
5 0.5 cm 10 1.043 1.272 0.847 1.021 
5 0.2 cm 25 1.110 1.440 0.969 1.030 
5 0.1 cm 50 1.210 1.695 1.022 1.113 
Table 4-2 The ratio of the segmented source to the full source in Excel using the raw 192Ir Monte 
Carlo data. 
   Excel Superposition ratios 
Total Length Length of Segments 
Number of 
Segments Average Max Min 
Transverse 
plane average 
3 1.5 cm 2 1.002 1.068 0.983 1.000 
3 1.0 cm 3 1.003 1.115 0.989 1.000 
3 2x0.5 cm + 2x1.0 cm 4 1.009 1.380 0.781 0.979 
3 2x0.8 cm + 2x0.7 cm 4 1.003 1.166 0.776 0.995 
3 0.6 cm 5 1.006 1.199 0.992 1.001 
3 0.5 cm 6 1.007 1.242 0.853 1.000 
3 0.3 cm 10 1.013 1.376 0.994 1.000 
3 0.2 cm 15 1.019 1.511 0.995 1.001 
3 0.1 cm 30 1.033 1.701 0.997 1.002 
       
5 2.5 cm 2 1.001 1.069 0.968 1.000 
5 1.0 cm 5 1.003 1.121 0.991 1.001 
5 0.5 cm 10 1.007 1.245 0.994 1.001 
5 0.2 cm 25 1.010 1.522 0.959 0.968 
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(a) (b) 
Figure 4-1 Plot of the number of line segments versus the transverse plane average dose for (a) 




Figure 4-2 Sample plot of the dose ratio of segmented source to the intact source for  
(a) 5.0 cm = 1.0cm+1.0cm+1.0cm+1.0cm+1.0cm and (b) 3.0 cm = 1.0cm+1.0cm+1.0cm. For 

























































































Figure 4-3 Plot of F(r,θ) for a variety of r values. 103Pd is on the left and 192Ir is on the right. The 
topmost pair is for L = 0.5 cm, the middle pair is for L = 1.0 cm and the bottom pair is for L = 5.0 
cm. As expected, F(r,θ) for all values approaches 1 as θ approaches 90º. This is expected as this 
is the reference point (r=1.0 cm, θ = 90º) and was chosen to be 1. Note that the F(r,θ) values for L 
= 0.5 cm and L = 1.0 cm are comparable. This was previously reported in the literature, however 





























Figure 4-4 g(r) for L = 0.5 cm, L = 1.0 cm and L = 5.0 cm. 103Pd is on the left and 192Ir is on the 
right. 
4.2 Pinnacle results 
A visual inspection of the Pinnacle results indicated agreement with the Excel 
results. Isodose lines that intersected the transverse plane remained constant over the 
range of line segments examined. However, the isodose lines that intersected the source 




Figure 4-5 Isodose maps for 103Pd. Each image contains four quadrants. The top left hand 
quadrant is the whole source in one segment. The top right hand quadrant is the source broken 
into two segments. The bottom left hand quadrant is the length broken into 1.0 cm segments, and 
the bottom right hand quadrant is the source broken into 0.1 cm lengths. The column on the left is 
a wide perspective as shown by the yellow ruler/scale, while the right hand column zooms in to a 
3.0 cm width. The blue circle is 1.0 cm in radius. The 5.0 cm lengths are on the top row and the 
bottom row is the 3.0 cm lengths. In all cases, the plane that bisects the source in the middle 
produced good results, while the results from the source long-axis deteriorated as the number of 




Figure 4-6 Similar approach to those in Figure 4-5, except for 192Ir. The results were also similar 
in that the comparison along the transverse plane produced good results while the results on the 
long axis diminished as the number of segments increased.  
4.3 IBA Dosimetry 
Comparisons were made with ΔDm set to both a 1% tolerance and a 2% tolerance 
within the IBA Dosimetry OmniPro I’mRT, with Δdm = 2.0 mm. In comparing the 3.0 cm 
length of 103Pd, three 1.0 cm segments produced the best comparison with 99.2% of the 
pixels passing ΔDm = 2%. For the 3.0 cm length of 
192Ir, the best results were for the 
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model comprised of three 1.0 cm segments, with 100.0% of the pixels passing for ΔDm = 
2%. Comparing these results to the LSS results of Meigooni et. al, showed a marked 
improvement in methodology. Their results averaged a 4% dose difference (with fewer 
positions across the dose grid reported), with a maximum difference of 14% for 103Pd. 
They did not simulate 192Ir so direct comparison is not possible. However, the results that 
are reported in this work demonstrate that the Tufts technique achieves a pass rate that is 
well within acceptable margins of error.8 
Comparing our results to the TLS method produced similar observations. The 
OmniPro-I’mRT Gamma comparison determined that, for the 103Pd 5.0 cm length, two 
2.5 cm segments yield the best results, with 98.7% of the pixels passing with ΔDm = 2%. 
192Ir had the best comparison for five 1.0 cm segments, with 99.7% passing with ΔDm = 
2%. This is an improvement over the TLS method, which had discrepancies of up to 
5.6% along the transverse plane. Additionally, the TLS method is not clinically 
implementable, while the Tufts technique is, which means that the results are not only 
numerically superior but also practicable. 
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Table 4-3 Percent of pixels passing a gamma test within OmniPro-I’mRT for both 103Pd and 192Ir. 
 Pd Ir 
3.0 cm 1 %, 2 mm 2 %, 2 mm 1 %, 2 mm 2 %, 2 mm
(n x mm) % % % % 
2 x 15.0 98.2 99.1 99.1 99.5 
3 x 10.0 98.5 99.2 99.8 100.0 
8.0+7.0+7.0+8.0 98.6 99.2 98.2 99.1 
5 x 6.0 97.7 98.4 99.5 99.8 
5.0 + 10.0 + 10.0 + 5.0 98.2 99.2 99.5 99.8 
6 x 5.0 97.8 99.2 99.2 99.8 
10 x 3.0 97.1 98.5 99.3 99.7 
15 x 2.0 97.0 98.2 98.9 99.5 
30 x 1.0 98.1 98.9 98.8 99.4 
     
5.0 cm     
(n x mm)     
2 x 25.0 97.5 98.7 98.3 99.1 
5 x 10.0 96.5 97.9 98.8 99.7 
10 x 5.0 94.8 98.0 98.1 99.0 
25 x 2.0 94.3 96.0 97.8 98.5 






Figure 4-7 Gamma comparison of the 5.0 cm length to the 5.0 cm length that was made up of five 
1.0 cm segments (left) and the 3.0 cm length to the three 1.0 cm segments (right). 103Pd is on the 




   
 
 
Figure 4-8 Comparison of the isodose lines of the 5.0 cm length to the five 1.0 cm segments (left) 
and of the 3.0 cm length to the three 1.0 cm lengths (right). 103Pd is on the top and 192Ir is on the 
bottom. The agreement is seen to be worst in the areas at the end of the source as well as very 
close to the source. However, overall agreement is quite good.  
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5  CHAPTER 5 
CLOSING 
As expected, the superposition principle for brachytherapy dose calculation 
worked upon dividing the elongated sources into smaller segments. Dosimetric 
differences were, on average, less than 1% in the majority of locations in the vicinity of 
each source. It is clear that the anisotropy of the elongated source needs to be one of the 
most important criteria in developing a series of suggestions for treatment planning.  
Techniques were developed that can be used clinically, making dosimetric 
calculations of elongated sources an easy task that can be undertaken to ensure patient 
safety. The Tufts technique permitted derivation of the anisotropy and radial dose 
functions on a clinical TPS.  
IBA dosimetry tools, which were developed for IMRT QA, were used in a novel 
way to analyze brachytherapy isodose curves. It is possible that this approach could be 
used to perform QA on patients who are implanted with brachytherapy sources, to 
compare the desired/ideal seed configuration to the actual outcome. A CT scan can be 
performed before the surgery, and the medical physicist and physician can work to decide 
the best placement of the source. After the surgery, another CT can be acquired and the 
real source placement can be calculated in Pinnacle. These two datasets can then be 
compared using the OmniPro-I’mRT software. 
The next step of this work is to move beyond straight-elongated sources and 
extend the analysis to curved sources and then curvilinear sources. In the practice of 
brachytherapy, it is necessary to have brachytherapy sources physically conform to the 
patient’s anatomy. One important question to answer is, “What is the correlation between 
the radius of a curved portion of a source and the straight-length approximation?” If the 
arc is approximated with a length that it too short, there is not enough attenuation and the 
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dose is too high. However, if the length is too long, it no longer conforms to the shape of 
the source and the self-attenuation becomes too great.  
Additionally, tables should be developed, using Monte Carlo techniques, for a 
variety of sources that can then be used as a standard set of segments to be used in 
treatment planning for elongated brachytherapy cases. From this research, it seems that 
longer segments will be more useful than shorter segments (i.e. <0.5 cm), since shorter 
segments are problematic in terms of accounting for dose anisotropy. These tables can 




1  H. Danlos and P. Bloch, "Note sur le traitement du lupus érythèmateux par des 
applications de radium," Ann. Dermatol. Syphil. 2, 986–988 (1901). 
2 R. Abbé, "Notes on the physiologic and therapeutic action of radium," Wash. Med. Ann. 
2, 363–377 (1904). 
3 A. G. Bell, "The uses of radium," Am. Med. 6, 261 (1903). 
4 S. B. Awan, A. S. Meigooni, R. Mokhberiosgouei, and M. Hussain, "Evaluation of TG-
43 recommended 2D-anisotropy function for elongated brachytherapy sources," Med. 
Phys. 33, 4271–4279 (2006). 
5 B. R. Thomadsen, J. F. Williamson, M. J. Rivard, and A. S. Meigooni, "Anniversary 
Paper: Past and current issues, and trends in brachytherapy physics," Med. Phys. 35, 
4708–4723 (2008). 
6 R. J. Shalek and M. A. Stovall, "Dosimetry in implant therapy," in Radiation Dosimetry 
vol 3, edited by F. H. Attix and E. Tochlin (Academic, New York, 1969), pp. 776–798. 
7  R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver, J. F. Williamson, and A. S. 
Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the 
AAPM Radiation Therapy Committee Task Group No. 43. American Association of 
Physicists in Medicine," Med. Phys. 22, 209–234 (1995). 
8 M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbott, M. 
G. Mitch, R. Nath, and J. F. Williamson, "Update of AAPM Task Group No. 43 Report: 
A revised AAPM protocol for brachytherapy dose calculations," Med. Phys. 31, 633–674 
(2004). 
9 M. J. Rivard, W. M. Butler, L. A. DeWerd, M. S. Huq, G. S. Ibbott, A. S. Meigooni, C. 
S. Melhus, M. G. Mitch, R. Nath, and J. F. Williamson, "Supplement to the 2004 update 
of the AAPM Task Group No. 43 Report," Med. Phys. 34, 2187–2205 (2007). 
10 P. Karaiskos, P. Papagiannis, A. Angelopoulos, L. Sakelliou, D. Baltas, P. Sandilos, 
and L. Vlachos, " Dosimetry of 192Ir wires for LDR interstitial brachytherapy following 
the AAPM TG-43 dosimetric formalism," Med. Phys. 28, 156–166 (2001). 
11 A. S. Meigooni, S. B. Awan, V. Rachabatthula, and R. A. Koona, "Treatment-planning 
considerations for prostate implants with the new linear RadioCoil™ 103Pd brachytherapy 
source, " J. Appl. Clin. Med. Phys. 6, 23–36 (2005). 
39 
 
12 R. van der Laarse, D. Granero, J. Perez-Calatayud, Ali. S. Meigooni, and F. Ballester, 
"Dosimetric characterization of Ir-192 LDR elongated sources," Med. Phys. 35, 1154–
1161 (2008). 
13 P. Karaiskos, A. Angelopoulos, P. Baras, H. Rozaki-Mavrouli, P. Sandilos, and L. 
Sakelliou, " Dose rate calculations around brachytherapy sources using a Sievert 
integration model," Phys. Med. Biol. 45, 383–397 (2000). 
14  A. S. Meigooni, H. Zhang, J. R. Clark, V. Rachabatthula, and R. A. Koona, 
"Dosimetric characteristics of the new RadioCoil™ 103Pd wire line source for use in 
permanent brachytherapy implants," Med. Phys. 31, 3095–3105 (2004). 
15 M. J. Rivard, C. S. Melhus, D. Granero, J. Perez-Calatayud, and F. Ballester, "An 
approach to using conventional brachytherapy software for clinical treatment planning of 
complex, Monte Carlo-based brachytherapy dose distributions," Med. Phys. 36, 1968–
1975 (2009). 
16 X-5 Monte Carlo Team, "MCNP: A general Monte Carlo N-particle transport code," 
Version 5, Los Alamos National Laboratory, Los Alamos, NM, 2003. 
17 M. White, " Photoatomic data library MCPLIB04: A new photoatomic library based on 
data from ENDF/B-VI release 8," Los Alamos National Laboratory Memorandum No. 
LAUR-03-1019, 2003. 
18 D. E. Cullen, J. H. Hubbell, and L. Kissel, "EPDL97: The Evaluated Photon Data 
Library, ‘97 Version," Lawrence Livermore National Laboratory Report No. UCRL-
50400 (19 September 1997). 
19 M. J. Rivard, D. Granero, J. Perez-Calatayud, and F. Ballester, "Influence of photon 
energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and 
dose rates in water and air," Med. Phys. 37, 869–876 (2010). 
20  C. S. Melhus and M. J. Rivard, "Approaches to calculating AAPM TG-43 
brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources," Med. 
Phys. 33, 1729–1737 (2006). 
21  F. Ballester, D. Granero, J. Perez-Calatayud, C. S. Melhus, and M. J. Rivard, 
"Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from 
emitted electrons," Med. Phys. 36, 4250–4256 (2009). 
22  NUDAT 2.4, National Nuclear Data Center, Brookhaven National Laboratory, 




23  NUDAT 2.4, National Nuclear Data Center, Brookhaven National Laboratory, 
http://www.nndc.bnl.gov/nudat2/decaysearchdirect.jsp?nuc=192Ir, (last accessed 8 
March 2010). 
24 M. Stock, B. Kroupa, and D. Georg, "Interpretation and evaluation of the gamma index 
and the gamma index angle for the verification of IMRT hybrid plans," Phys. Med. Biol. 
50, 399–411 (2005). 
